HM Payson & Co’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $137K | Buy |
2,620
+17
| +0.7% | +$892 | ﹤0.01% | 475 |
|
2024
Q4 | $143K | Buy |
2,603
+18
| +0.7% | +$990 | ﹤0.01% | 476 |
|
2024
Q3 | $130K | Buy |
2,585
+15
| +0.6% | +$754 | ﹤0.01% | 486 |
|
2024
Q2 | $113K | Buy |
2,570
+45
| +2% | +$1.98K | ﹤0.01% | 483 |
|
2024
Q1 | $111K | Buy |
2,525
+19
| +0.8% | +$836 | ﹤0.01% | 491 |
|
2023
Q4 | $119K | Hold |
2,506
| – | – | ﹤0.01% | 471 |
|
2023
Q3 | $111K | Hold |
2,506
| – | – | ﹤0.01% | 467 |
|
2023
Q2 | $120K | Buy |
2,506
+30
| +1% | +$1.43K | ﹤0.01% | 447 |
|
2023
Q1 | $97.4K | Buy |
2,476
+12
| +0.5% | +$472 | ﹤0.01% | 476 |
|
2022
Q4 | $69.7K | Hold |
2,464
| – | – | ﹤0.01% | 515 |
|
2022
Q3 | $74K | Hold |
2,464
| – | – | ﹤0.01% | 514 |
|
2022
Q2 | $84K | Hold |
2,464
| – | – | ﹤0.01% | 496 |
|
2022
Q1 | $110K | Sell |
2,464
-1,992
| -45% | -$88.9K | ﹤0.01% | 478 |
|
2021
Q4 | $206K | Buy |
4,456
+16
| +0.4% | +$740 | ﹤0.01% | 399 |
|
2021
Q3 | $149K | Buy |
4,440
+7
| +0.2% | +$235 | ﹤0.01% | 428 |
|
2021
Q2 | $130K | Buy |
4,433
+28
| +0.6% | +$821 | ﹤0.01% | 440 |
|
2021
Q1 | $114K | Buy |
4,405
+45
| +1% | +$1.17K | ﹤0.01% | 464 |
|
2020
Q4 | $99K | Hold |
4,360
| – | – | ﹤0.01% | 476 |
|
2020
Q3 | $93K | Hold |
4,360
| – | – | ﹤0.01% | 459 |
|
2020
Q2 | $101K | Hold |
4,360
| – | – | ﹤0.01% | 429 |
|
2020
Q1 | $93K | Hold |
4,360
| – | – | ﹤0.01% | 413 |
|
2019
Q4 | $102K | Hold |
4,360
| – | – | ﹤0.01% | 466 |
|
2019
Q3 | $92K | Hold |
4,360
| – | – | ﹤0.01% | 486 |
|
2019
Q2 | $89K | Buy |
+4,360
| New | +$89K | ﹤0.01% | 508 |
|